Cardio Diagnostics Holdings, Inc. (CDIO): Shareholders' Equity
$6.97M
As of 2025-12-31
$7.43M
As of 2026-06-30
+17.5%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.97M | -27.0% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $9.56M | +223.1% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $2.96M | -31.2% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $4.30M | +302.7% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $1.07M | n/a | 2023-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | $6.97M | -27.0% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $527.16M | -29.4% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$34.25M | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$31.46M | n/m |
| Biomerica Inc (BMRA) | 2026-05-31 | $2.63M | -35.9% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.16M | +75.4% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$6.93M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | $27.06M | -1.7% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $68.78M | -16.5% |
Compare CDIO, CLDX, VNRX, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗